P1036a (DAIDS ID 10193): Directly Observed Therapy in HIV-Infected Adolescents: Part A - Focus Groups
| Study Status | Study Restriction |
|---|---|
Concluded |
United States |
What is P1036a?
P1036a was a focus group to inform the Directly Observed Therapy (DOT) intervention model. The study was designed to obtain information for a DOT intervention model that will be accepted by adolescents and was used to inform P1036b.
Study documents:
Sites where the study is implemented:
| CRS ID | Site Name | City | Country |
|---|---|---|---|
University of Miami Pediatric/Perinatal HIV/AIDS |
Miami |
United States of America |
|
University of Southern California LA |
Los Angeles |
United States of America |
|
St. Jude/UTHSC CRS |
Memphis |
United States of America |
Study contacts:
Study Chair: Patricia Flynn |
Study Vice-Chair: Marvin Belzer |
Investigator: Aditya Gaur |
Investigator: George McSherry |
Laboratory Technologist: William Kabat |
Medical Officer: Audrey Rogers |
Neuropsychologist: Patricia Garvie |
Pharmacologist: Francesca Aweeka |
Pharmacologist: Lynette Purdue |
Statistician: Hu Chengcheng |
Virologist: Stephen Spector |